An Open Label Study to Evaluate the Safety and Effect on Treatment Response of MabThera in Patients With Rheumatoid Arthritis Following Inadequate Response to One Prior Anti-TNF Inhibitor
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Rituximab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Roche
- 31 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2012 Actual patient number is 60 as reported by ClinicalTrials.gov.
- 06 Jul 2012 Planned end date changed from 1 Jan 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.